Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The heart in muscular dystrophy.

Larry W Markham1, Robert L Spicer, Linda H Cripe

  • 1Cincinnati Children's Hospital Medical Center, Department of Pediatrics, Division of Pediatric Cardiology, Cincinnati, OH 45229, USA.

Pediatric Annals
|August 12, 2005
PubMed
Summary

Pediatricians must monitor for heart issues in muscular dystrophy (MD) patients, as symptoms can be subtle. Early detection and treatment of cardiac involvement improve outcomes for children with MD.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low Albumin and Elevated FIB-4 Are Associated With Adverse Outcomes After the Fontan Procedure.

Heart, lung & circulation·2026
Same author

Assessing movement quality in individuals with Duchenne muscular dystrophy utilizing accelerometry: Comparisons with healthy controls.

PLOS digital health·2026
Same author

Adult Congenital Heart Disease Workforce Challenges in the United States: Current State and Future Needs: Proceedings from the American College of Cardiology (ACC), Adult Congenital Pediatric Cardiology (ACPC) Council Adult Congenital Heart Disease Summit.

JACC. Advances·2026
Same author

Empagliflozin preserves cardiac function and modulates metabolism in a mouse model of Duchenne muscular dystrophy.

bioRxiv : the preprint server for biology·2026
Same author

Variant burden and severity of cardiomyopathy in patients with DMD-related Duchenne muscular dystrophy.

Pediatric research·2026
Same author

Six-Minute Activity-95<sup>th</sup> Centile, a Novel Wearable-Derived Clinical Outcome Assessment for Duchenne Muscular Dystrophy.

Pediatric neurology·2025

Area of Science:

  • Cardiology
  • Neurology
  • Pediatrics

Background:

  • Muscular dystrophy (MD) is a group of genetic disorders characterized by progressive skeletal muscle weakness.
  • Cardiac involvement is a common and serious complication of MD, significantly contributing to morbidity and mortality.
  • Subclinical cardiac involvement is frequent, making early detection challenging.

Purpose of the Study:

  • To emphasize the importance of vigilant cardiac monitoring in pediatric patients with MD.
  • To highlight the need for early identification and management of cardiac complications.
  • To discuss current and future therapeutic strategies for managing cardiac involvement in MD.

Main Methods:

  • Review of clinical presentation and diagnostic approaches for cardiac involvement in MD.
  • Discussion of noninvasive cardiac testing modalities.
  • Analysis of current treatment strategies and their impact on disease outcomes.

Main Results:

  • Cardiac involvement in MD patients can present with minimal or no overt symptoms.
  • Thorough clinical evaluation, including interval history and physical examination, is crucial.
  • Noninvasive cardiac testing aids in the early detection of subclinical cardiac dysfunction.

Conclusions:

  • Healthcare professionals must maintain a high index of suspicion for cardiac involvement in all pediatric MD patients.
  • Timely and appropriate cardiac evaluation and management can mitigate disease progression and improve survival.
  • While genetic engineering offers future hope, current advancements in clinical care and supportive management significantly benefit affected children.

Related Experiment Videos